{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T16:07:44Z","timestamp":1786550864426,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.arteri.2025.500822","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T15:03:02Z","timestamp":1748876582000},"page":"500822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S1","title":["Hipertrigliceridemia (> 150 mg\/dl) como marcador de riesgo cardiovascular"],"prefix":"10.1016","volume":"37","author":[{"given":"Jos\u00e9","family":"L\u00f3pez-Miranda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arteri.2025.500822_bib0310","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: Pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Boren","year":"2020","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500822_bib0315","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","article-title":"Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: New insights from epidemiology, genetics, and biology","volume":"118","author":"Nordestgaard","year":"2016","journal-title":"Circ Res."},{"key":"10.1016\/j.arteri.2025.500822_bib0320","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/01.ATV.15.4.534","article-title":"Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media","volume":"15","author":"Nordestgaard","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1016\/j.arteri.2025.500822_bib0325","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: Evidence and guidance for management","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500822_bib0330","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1373\/clinchem.2010.157164","article-title":"Nonfasting lipids, lipoproteins, and apolipoproteins in individuals with and without diabetes: 58434 individuals from the Copenhagen General Population Study","volume":"57","author":"Langsted","year":"2011","journal-title":"Clin Chem."},{"key":"10.1016\/j.arteri.2025.500822_bib0335","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","article-title":"Triglycerides and cardiovascular disease","volume":"384","author":"Nordestgaard","year":"2014","journal-title":"Lancet."},{"key":"10.1016\/j.arteri.2025.500822_bib0340","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1161\/01.CIR.97.11.1029","article-title":"Triglyceride concentration and ischemic heart disease: An eight-year follow-up in the Copenhagen Male Study","volume":"97","author":"Jeppesen","year":"1998","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2025.500822_bib0345","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00043798-199604000-00014","article-title":"Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies","volume":"3","author":"Hokanson","year":"1996","journal-title":"J Cardiovasc Risk."},{"key":"10.1016\/j.arteri.2025.500822_bib0350","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","article-title":"Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies","volume":"115","author":"Sarwar","year":"2007","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2025.500822_bib0355","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.amjcard.2009.04.008","article-title":"Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in End-Points through Aggressive Lipid Lowering trials of statins in patients with coronary artery disease","volume":"104","author":"Faergeman","year":"2009","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.arteri.2025.500822_bib0360","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJM199304293281702","article-title":"Plasma triglyceride level and mortality from coronary heart disease","volume":"328","author":"Criqui","year":"1993","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2025.500822_bib0365","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.diabres.2011.12.018","article-title":"Impact of diabetes, high triglycerides and low HDL cholesterol on risk for ischemic cardiovascular disease varies by LDL cholesterol level: A 15-year follow-up of the Chinese Multi-provincial Cohort Study","volume":"96","author":"Liu","year":"2012","journal-title":"Diabetes Res Clin Pract."},{"key":"10.1016\/j.arteri.2025.500822_bib0370","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJM198006193022503","article-title":"Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease","volume":"302","author":"Hulley","year":"1980","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2025.500822_bib0375","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1194\/jlr.M300272-JLR200","article-title":"Genome-wide scan for quantitative trait loci influencing LDL size and plasma triglyceride in familial hypertriglyceridemia","volume":"44","author":"Austin","year":"2003","journal-title":"J Lipid Res."},{"key":"10.1016\/j.arteri.2025.500822_bib0380","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.jacc.2017.08.006","article-title":"A test in context: Lipid profile, fasting versus nonfasting","volume":"70","author":"Nordestgaard","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2025.500822_bib0385","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.108.804146","article-title":"Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction","volume":"118","author":"Langsted","year":"2008","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2025.500822_bib0390","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","article-title":"Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women","volume":"298","author":"Nordestgaard","year":"2007","journal-title":"JAMA."},{"key":"10.1016\/j.arteri.2025.500822_bib0395","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.jacc.2020.10.008","article-title":"Remnant cholesterol, not LDL cholesterol, is associated with incident cardiovascular disease","volume":"76","author":"Castaner","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2025.500822_bib0400","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ana.25432","article-title":"Remnant cholesterol and risk of ischemic stroke in 112,512 individuals from the general population","volume":"85","author":"Varbo","year":"2019","journal-title":"Ann Neurol."},{"key":"10.1016\/j.arteri.2025.500822_bib0405","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1093\/eurheartj\/ehab705","article-title":"Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: A cohort-based study","volume":"43","author":"Wadstrom","year":"2022","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500822_bib0410","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1093\/eurheartj\/ehab293","article-title":"Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction","volume":"42","author":"Varbo","year":"2021","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500822_bib0415","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.jacc.2020.02.059","article-title":"Triglyceride-rich lipoprotein cholesterol, small dense LDL cholesterol, and incident cardiovascular disease","volume":"75","author":"Duran","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2025.500822_bib0420","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1016\/j.jacc.2020.09.610","article-title":"VLDL cholesterol accounts for one-half of the risk of myocardial infarction associated with apoB-containing lipoproteins","volume":"76","author":"Balling","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2025.500822_bib0425","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/jamacardio.2020.0013","article-title":"A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and\/or hypertriglyceridemia","volume":"5","author":"Sampson","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.arteri.2025.500822_bib0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u2018Mendelian randomization\u2019: Can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Smith","year":"2003","journal-title":"Int J Epidemiol."},{"key":"10.1016\/j.arteri.2025.500822_bib0435","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/eurheartj\/ehs431","article-title":"Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction","volume":"34","author":"J\u00f8rgensen","year":"2013","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500822_bib0440","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","article-title":"Remnant cholesterol as a causal risk factor for ischemic heart disease","volume":"61","author":"Varbo","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2025.500822_bib0445","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1161\/CIRCULATIONAHA.113.003008","article-title":"Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation","volume":"128","author":"Varbo","year":"2013","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2025.500822_bib0450","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/eurheartj\/ehaa972","article-title":"Metabolic profiling of angiopoietin-like protein 3 and 4 inhibition: A drug-target Mendelian randomization analysis","volume":"42","author":"Wang","year":"2021","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500822_bib0455","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1161\/ATVBAHA.118.312021","article-title":"Metabolomic signature of angiopoietin-like protein 3 deficiency in fasting and postprandial state","volume":"39","author":"Tikkanen","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1016\/j.arteri.2025.500822_bib0460","doi-asserted-by":"crossref","first-page":"e3001547","DOI":"10.1371\/journal.pbio.3001547","article-title":"Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation","volume":"20","author":"Richardson","year":"2022","journal-title":"PLoS Biol."},{"key":"10.1016\/j.arteri.2025.500822_bib0465","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.jacc.2014.09.042","article-title":"Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease","volume":"64","author":"Rosenson","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2025.500822_bib0470","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/jama.2018.20045","article-title":"Association of triglyceride-lowering LPL variants and LDL-C-lowering LDLR variants with risk of coronary heart disease","volume":"321","author":"Ference","year":"2019","journal-title":"JAMA."},{"key":"10.1016\/j.arteri.2025.500822_bib0475","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1093\/eurheartj\/ehad337","article-title":"Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: A UK Biobank study","volume":"44","author":"Bjornson","year":"2023","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500822_bib0480","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1093\/eurheartj\/ehad419","article-title":"Triglyceride-rich remnant lipoproteins are more atherogenic than LDL per particle: Is this important?","volume":"44","author":"Tybjaerg-Hansen","year":"2023","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500822_bib0485","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jacl.2023.04.007","article-title":"APOC3 inhibition with volanesorsen reduces hepatic steatosis in patients with severe hypertriglyceridemia","volume":"17","author":"Prohaska","year":"2023","journal-title":"J Clin Lipidol."},{"key":"10.1016\/j.arteri.2025.500822_bib0490","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrendo.2017.119","article-title":"Angiopoietin-like 3 in lipoprotein metabolism","volume":"13","author":"Kersten","year":"2017","journal-title":"Nat Rev Endocrinol."},{"key":"10.1016\/j.arteri.2025.500822_bib0495","doi-asserted-by":"crossref","first-page":"104543","DOI":"10.1016\/j.ebiom.2023.104543","article-title":"Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease","volume":"90","author":"Li","year":"2023","journal-title":"EBioMedicine."},{"key":"10.1016\/j.arteri.2025.500822_bib0500","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: A scientific statement from the American Heart Association","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1016\/j.arteri.2025.500822_bib0505","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0140-6736(10)60545-4","article-title":"Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet."},{"key":"10.1016\/j.arteri.2025.500822_bib0510","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1126\/science.1161524","article-title":"A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection","volume":"322","author":"Pollin","year":"2008","journal-title":"Science."},{"key":"10.1016\/j.arteri.2025.500822_bib0515","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1308027","article-title":"Loss-of-function mutations in APOC3 and risk of ischemic vascular disease","volume":"371","author":"J\u00f8rgensen","year":"2014","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2025.500822_bib0520","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1307095","article-title":"Loss-of-function mutations in APOC3, triglycerides, and coronary disease","volume":"371","author":"Crosby","year":"2014","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2025.500822_bib0525","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cmet.2014.08.007","article-title":"APOC3, coronary disease, and complexities of Mendelian randomization","volume":"20","author":"Cohen","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.arteri.2025.500822_bib0530","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1373\/clinchem.2013.219881","article-title":"Low nonfasting triglycerides and reduced all-cause mortality: A Mendelian randomization study","volume":"60","author":"Thomsen","year":"2014","journal-title":"Clin Chem."},{"key":"10.1016\/j.arteri.2025.500822_bib0535","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1161\/01.ATV.8.4.421","article-title":"Reduced atherogenesis in cholesterol-fed diabetic rabbits. Giant lipoproteins do not enter the arterial wall","volume":"8","author":"Nordestgaard","year":"1988","journal-title":"Arteriosclerosis."},{"key":"10.1016\/j.arteri.2025.500822_bib0540","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.ATV.14.11.1767","article-title":"Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoproteinB immunosorption from human atherosclerotic plaque","volume":"14","author":"Rapp","year":"1994","journal-title":"Arterioscler Thromb."},{"key":"10.1016\/j.arteri.2025.500822_bib0545","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/S0021-9258(19)85958-6","article-title":"Cholesteryl ester accumulation in macrophages resulting from receptor-mediated uptake and degradation of hypercholesterolemic canine beta-very low density lipoproteins","volume":"255","author":"Goldstein","year":"1980","journal-title":"J Biol Chem."},{"key":"10.1016\/j.arteri.2025.500822_bib0550","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1161\/01.ATV.17.4.715","article-title":"The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial","volume":"17","author":"Alaupovic","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1016\/j.arteri.2025.500822_bib0555","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrcardio.2017.31","article-title":"Hypertriglyceridaemia and risk of coronary artery disease","volume":"14","author":"Reiner","year":"2017","journal-title":"Nat Rev Cardiol."},{"key":"10.1016\/j.arteri.2025.500822_bib0560","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.113.301375","article-title":"Induction of ATF3 gene network by triglyceride-rich lipoprotein lipolysis products increases vascular apoptosis and inflammation","volume":"33","author":"Aung","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1016\/j.arteri.2025.500822_bib0565","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1074\/jbc.M008725200","article-title":"Elevated triglyceride content diminishes the capacity of high density lipoprotein to deliver cholesteryl esters via the scavenger receptor classB typeI (SR-BI)","volume":"276","author":"Greene","year":"2001","journal-title":"J Biol Chem."},{"key":"10.1016\/j.arteri.2025.500822_bib0570","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1194\/jlr.M100431-JLR200","article-title":"LDL and HDL enriched in triglyceride promote abnormal cholesterol transport","volume":"43","author":"Skeggs","year":"2002","journal-title":"J Lipid Res."},{"key":"10.1016\/j.arteri.2025.500822_bib0575","doi-asserted-by":"crossref","first-page":"e78322","DOI":"10.1371\/journal.pone.0078322","article-title":"Triglyceride-rich lipoprotein modulates endothelial vascular cell adhesion molecule (VCAM)-1 expression via differential regulation of endoplasmic reticulum stress","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One."},{"key":"10.1016\/j.arteri.2025.500822_bib0580","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.atherosclerosis.2016.03.035","article-title":"Relationship between serum triglyceride levels and endothelial function in a large community-based study","volume":"249","author":"Kajikawa","year":"2016","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2025.500822_bib0585","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12944-016-0266-8","article-title":"Triglycerides are a predictive factor for arterial stiffness: A community-based 4.8-year prospective study","volume":"15","author":"Wang","year":"2016","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.arteri.2025.500822_bib0590","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/01.ATV.12.1.6","article-title":"Influx in vivo of low density, intermediate density, and very low density lipoproteins into aortic intimas of genetically hyperlipidemic rabbits. Roles of plasma concentrations, extent of aortic lesion, and lipoprotein particle size as determinants","volume":"12","author":"Nordestgaard","year":"1992","journal-title":"Arterioscler Thromb."},{"key":"10.1016\/j.arteri.2025.500822_bib0595","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1161\/ATVBAHA.111.226100","article-title":"Triglycerides and heart disease: still a hypothesis?","volume":"31","author":"Goldberg","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1016\/j.arteri.2025.500822_bib0600","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11883-013-0365-1","article-title":"Lipids and the endothelium: Bidirectional interactions","volume":"15","author":"Goldberg","year":"2013","journal-title":"Curr Atheroscler Rep."},{"key":"10.1016\/j.arteri.2025.500822_bib0605","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI115747","article-title":"Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques","volume":"89","author":"O\u2019Brien","year":"1992","journal-title":"J Clin Invest."},{"key":"10.1016\/j.arteri.2025.500822_bib0610","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jacl.2010.02.011","article-title":"No evidence of impaired endothelial function or altered inflammatory state in patients with familial hypercholesterolemia treated with statins","volume":"4","author":"Hovland","year":"2010","journal-title":"J Clin Lipidol."}],"container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916825000658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916825000658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:25:37Z","timestamp":1758122737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0214916825000658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":61,"alternative-id":["S0214916825000658"],"URL":"https:\/\/doi.org\/10.1016\/j.arteri.2025.500822","relation":{},"ISSN":["0214-9168"],"issn-type":[{"value":"0214-9168","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hipertrigliceridemia (>150mg\/dl) como marcador de riesgo cardiovascular","name":"articletitle","label":"Article Title"},{"value":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arteri.2025.500822","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author. Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Arteriosclerosis.","name":"copyright","label":"Copyright"}],"article-number":"500822"}}